These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8809516)

  • 1. Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S).
    Jönsson B; Johannesson M; Kjekshus J; Olsson AG; Pedersen TR; Wedel H
    Eur Heart J; 1996 Jul; 17(7):1001-7. PubMed ID: 8809516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group.
    Johannesson M; Jönsson B; Kjekshus J; Olsson AG; Pedersen TR; Wedel H
    N Engl J Med; 1997 Jan; 336(5):332-6. PubMed ID: 9011785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 4S study and its pharmacoeconomic implications.
    Reckless JP
    Pharmacoeconomics; 1996 Feb; 9(2):101-5. PubMed ID: 10172696
    [No Abstract]   [Full Text] [Related]  

  • 4. Scandinavian simvastatin study (4S).
    Grodos D; Tonglet R
    Lancet; 1994 Dec 24-31; 344(8939-8940):1768. PubMed ID: 7997017
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S).
    Pyŏrälä K; Pedersen TR; Kjekshus J; Faergeman O; Olsson AG; Thorgeirsson G
    Diabetes Care; 1997 Apr; 20(4):614-20. PubMed ID: 9096989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
    Plans-Rubió P
    Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S).
    Kjekshus J; Pedersen TR
    Am J Cardiol; 1995 Sep; 76(9):64C-68C. PubMed ID: 7572690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: life table method applied to health authority population.
    Pharoah PD; Hollingworth W
    BMJ; 1996 Jun; 312(7044):1443-8. PubMed ID: 8664620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary artery disease: the Scandinavian Simvastatin Survival Study experience.
    Pedersen TR
    Am J Cardiol; 1998 Nov; 82(10B):53T-56T. PubMed ID: 9860376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin. A reappraisal of its cost effectiveness in dyslipidaemia and coronary heart disease.
    Goa KL; Barradell LB; McTavish D
    Pharmacoeconomics; 1997 Jan; 11(1):89-110. PubMed ID: 10172918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scandinavian simvastatin study (4S).
    Smith GD; Pekkanen J
    Lancet; 1994 Dec 24-31; 344(8939-8940):1766; author reply 1767-8. PubMed ID: 7864990
    [No Abstract]   [Full Text] [Related]  

  • 12. The 4S study. Implications for prescribing.
    van Boven AJ; Brügemann J; de Graeff PA; May JF; Crijns HJ
    Drugs; 1996 Apr; 51(4):507-14. PubMed ID: 8706591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease.
    Haffner SM
    Diabetes Care; 1997 Apr; 20(4):469-71. PubMed ID: 9096961
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
    Lancet; 1994 Nov; 344(8934):1383-9. PubMed ID: 7968073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cost-effectiveness of lowering of blood cholesterol using simvastatin and cholestyramine].
    Martens LL; Rutten FF; Kuijpens JL; Winter J
    Ned Tijdschr Geneeskd; 1991 Apr; 135(15):655-9. PubMed ID: 1903849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical benefits and cost-effectiveness of lowering serum cholesterol levels: the case of simvastatin and cholestyramine in The Netherlands.
    Martens LL; Rutten FF; Erkelens DW; Ascoop CA
    Am J Cardiol; 1990 Mar; 65(12):27F-32F. PubMed ID: 2107736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S).
    Lancet; 1995 May; 345(8960):1274-5. PubMed ID: 7746058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of simvastatin in the secondary prevention of coronary artery disease in Canada.
    Rivière M; Wang S; Leclerc C; Fitzsimon C; Tretiak R
    CMAJ; 1997 Apr; 156(7):991-7. PubMed ID: 9099167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) study after the Scandinavian Simvastatin Survival Study (4S).
    Tonkin AM
    Am J Cardiol; 1995 Sep; 76(9):107C-112C. PubMed ID: 7572678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scandinavian simvastatin study (4S).
    Manzato E
    Lancet; 1994 Dec 24-31; 344(8939-8940):1767; author reply 1767-8. PubMed ID: 7997016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.